Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

678515.pdf (141.69 KB)

Document type

Article

Version

Published version

Publication date

2017-02-05

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/123378

What drives country differences in cost of Alzheimer's Disease? An explanation from resource use in the GERAS Study

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.3233/JAD-160449

Abstract

BACKGROUND: Country differences in resource use and costs of Alzheimer's disease (AD) may be driven by differences in health care systems and resource availability. OBJECTIVE: To compare country resource utilization drivers of societal costs for AD dementia over 18 months. METHODS: GERAS is an observational study in France (n = 419), Germany (n = 550), and the UK (n = 526). Resource use of AD patients and caregivers contributing to >1% of total societal costs (year 2010) was assessed for country differences, adjusting for participant characteristics. RESULTS: Mean 18-month societal costs per patient were France ¿33,339, Germany ¿38,197, and UK ¿37,899 (£32,501). Caregiver time spent on basic and instrumental activities of daily living (ADL) contributed the most to societal costs (54% France, 64% Germany, 65% UK). Caregivers in France spent less time on ADL than UK caregivers and missed fewer work days than in other countries. Compared with other countries, patients in France used more community care services overall and were more likely to use home aid. Patients in Germany were least likely to use temporary accommodation or to be institutionalized at 18 months. UK caregivers spent the most time on instrumental ADL, UK patients used fewest outpatient resources, and UK patients/caregivers were most likely to receive financial support. CONCLUSION: Caregiver time on ADL contributed the most to societal costs and differed across countries, possibly due to use of community care services and institutionalization. Other resources had different patterns of use across countries, reflecting country-specific health and social care systems.

Subject

Malaltia d'Alzheimer, Cuidadors, Qualitat de vida, Atenció domiciliària, França, Alemanya (República Federal), Anglaterra

Subject (English)

Alzheimer's disease, Caregivers, Quality of life, Home care services, France, Germany (West), England

Citation

Collections

Articles publicats en revistes (Medicina)

Citation

REED, Catherine, et al. What drives country differences in cost of Alzheimer's Disease? An explanation from resource use in the GERAS Study. Journal of Alzheimer's Disease. 2017. Vol. 57, num. 3, pags. 797-812. ISSN 1387-2877. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/123378

Export metadata

JSON - METS

Share record